Details for 2014799089

Up to date per 02.04.2026

Actions

Title / Product Name

SPEZIFISCHE ANTIKÖRPER GEGEN CD38 ZUR BEHANDLUNG VON MENSCHLICHEM KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014799089

EP Publication Number

3063173

E-Number

1295677

Language

PCT Number

US14063380

Publication Date

07.09.2016 A

29.07.2020 B1

Registration Date

29.07.2020

AT Publication Date

15.08.2020

Application Date

31.10.2014

Registration Number

Priorities

31.10.2013

201361898309 P

31.07.2014

14306220

IPC

C07K 16/28 20060101AFI20150515BHEP

Maximum Duration of Protection

31.10.2034

Owner

Sanofi-Aventis U.S. LLC.100 Morris Street Morristown, New JerseyUS

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

DESLANDES, Antoinec/o Sanofi 55 Corporate Drive Mail Code: 55a-505a Bridgewater, NJ 08807US

GRZEGORZEWSKI, Krzysztof, J.35 Everdale Road Randolph, NJ 07869US

OZOUX, Marie-laurec/o Sanofi 55 Corporate Drive Mail Code: 55a-505a Bridgewater, NJ 08807US

TOMKINSON, Blake101 Sunset Road Weston, MA 02493US

Information about Fees